Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone and Smoked Marijuana Interaction
NCT00743145Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- May 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of naltrexone in cannabis use disorder (CUD) (6 arms), sponsored by New York State Psychiatric Institute. Primary endpoint: Subjective Marijuana Effects at 180 minutes. Started May 2008; status: completed.
02
Drugs
naltrexone
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00743145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743145.